Fortress Biotech, Inc. - Preferred Stock - Laporan Laba Rugi (TTM)

Fortress Biotech, Inc. - Preferred Stock

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Fortress Biotech, Inc. - Preferred Stock menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 43 46 44 53 64 69 81 82 78 76 64 63 62 85 85 83 82 58 58 59
Change (%) 6.09 -2.92 18.94 22.05 7.04 17.94 1.29 -5.55 -2.41 -15.18 -2.33 -1.24 36.38 0.71 -2.93 -1.36 -29.23 0.19 2.63
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 60 79 84 105 131 161 179 178 175 166 170 169 155 129 114 92 80 78 56 50
Change (%) 31.13 6.52 24.95 24.68 23.22 10.97 -0.31 -1.50 -5.55 2.55 -0.50 -8.01 -17.05 -11.72 -18.91 -13.05 -3.14 -28.44 -9.56
% of Revenue 139.64 172.60 189.39 198.96 203.25 233.97 220.16 216.69 225.98 218.70 264.42 269.38 250.89 152.60 133.76 111.74 98.50 134.82 96.30 84.87
Gross Operating Profit -17 -33 -40 -52 -66 -92 -97 -96 -98 -90 -106 -106 -94 -44 -29 -10 1 -20 2 9
Change (%) 94.28 19.53 31.68 27.34 38.90 5.78 -1.64 1.97 -8.05 17.49 0.61 -12.02 -52.46 -35.35 -66.25 -112.61 -1,742.27 -110.64 319.98
% of Revenue -39.64 -72.60 -89.39 -98.96 -103.25 -133.97 -120.16 -116.69 -125.98 -118.70 -164.42 -169.38 -150.89 -52.60 -33.76 -11.74 1.50 -34.82 3.70 15.13
SG&A 60 61 63 68 75 87 96 105 113 114 113 108 100 88 80 77 77 84 92 110
Change (%) 2.48 3.31 7.80 10.04 15.86 10.05 10.11 7.52 0.44 -0.82 -4.09 -7.78 -11.91 -8.42 -4.48 0.34 9.01 9.19 19.53
% of Revenue 138.87 134.14 142.74 129.36 116.63 126.24 117.80 128.07 145.79 150.05 175.46 172.31 160.90 103.93 94.51 92.99 94.60 145.71 158.80 184.96
R&D 24
Change (%)
% of Revenue 54.96
OpEx 143 140 147 173 206 248 274 283 289 279 283 277 255 221 199 175 163 161 147 159
Change (%) -2.41 5.12 17.58 18.91 20.54 10.65 3.32 1.85 -3.20 1.18 -1.93 -7.92 -13.57 -9.84 -12.23 -6.75 -1.29 -8.80 8.77
% of Revenue 333.48 306.74 332.13 328.32 319.88 360.21 337.96 344.76 371.77 368.76 439.88 441.68 411.79 260.99 233.65 211.26 199.72 278.58 253.58 268.77
Operating Income -100 -94 -103 -120 -141 -179 -193 -201 -211 -204 -218 -214 -193 -136 -114 -92 -81 -103 -89 -100
Change (%) -6.06 9.00 16.99 17.54 26.68 7.85 4.18 4.88 -3.49 7.27 -1.82 -9.88 -29.58 -16.39 -19.19 -11.60 26.73 -13.83 12.77
% of Revenue -233.48 -206.74 -232.13 -228.32 -219.88 -260.21 -237.96 -244.76 -271.77 -268.76 -339.88 -341.68 -311.79 -160.99 -133.65 -111.26 -99.72 -178.58 -153.58 -168.77
Interest Expense -16 -15 -14 -14 -12 -15 -15 -16 -15 -14 -16 -19 -18 -15 -14 -9 -9 -14 -14 -14
Change (%) -5.67 -6.11 -2.08 -17.84 32.23 1.05 2.55 -6.63 -7.90 14.26 20.98 -4.55 -14.92 -11.06 -31.59 0.99 43.75 1.50 2.89
% of Revenue -37.80 -33.61 -32.51 -26.76 -18.01 -22.25 -19.07 -19.30 -19.08 -18.01 -24.26 -30.06 -29.05 -18.12 -16.00 -11.28 -11.55 -23.45 -23.76 -23.82
Net Income -57 -47 -43 -33 -38 -65 -72 -89 -91 -87 -92 -96 -78 -61 -55 -41 -49 -46 -41 -15
Change (%) -17.98 -7.63 -22.75 15.77 68.35 10.72 24.88 1.93 -5.06 6.67 3.70 -18.24 -22.56 -10.09 -25.36 19.22 -5.18 -10.51 -64.22
% of Revenue -131.98 -102.03 -97.09 -63.05 -59.80 -94.06 -88.31 -108.87 -117.49 -114.30 -143.75 -152.63 -126.36 -71.75 -64.05 -49.25 -59.52 -79.75 -71.24 -24.84

Source: Capital IQ

Other Listings
DE:CNB0 € 7.25
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista